Mitral Annular Disjunction Associated with Ventricular Dilation in Pediatric Marfan Syndrome: A Cardiovascular

Ryan S Bishop1,2, Tam T Doan3,4, Natalie K Craik3,4

  • 1Division of Cardiology, Texas Children's Hospital, Baylor College of Medicine, 6651 Main Street MC-E1920, Houston, TX, 77030, USA. ryan.bishop@bcm.edu.

Pediatric Cardiology
|October 28, 2024
PubMed
Abstract

Insights

Mitral annular disjunction (MAD) is linked to left ventricular (LV) dilation in pediatric Marfan syndrome (MFS) patients, independent of mitral valve prolapse. This finding highlights MAD as a key indicator of cardiac changes in young MFS individuals.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Cardiovascular Imaging

Background:

  • Mitral annular disjunction (MAD) is an emerging marker for adverse cardiovascular events in Marfan syndrome (MFS).
  • Previous adult studies suggest a link between MFS, left ventricular (LV) dilation, and reduced ejection fraction (LVEF).

Purpose of the Study:

  • To investigate the association between MAD and LV dilation in pediatric MFS patients.
  • To determine if MAD is an independent predictor of LV dilation in this population.

Main Methods:

  • Retrospective analysis of pediatric MFS patients (<19 years) using cardiac MRI (CMR) or echocardiography.
  • Assessment of MAD and mitral valve prolapse (MVP).
  • Measurement of LV volumes (LVEDV, LVESV), indexed volumes, z-scores, and LVEF, excluding significant volume load from regurgitation.

Main Results:

  • MAD was present in 66.7% of the 42 analyzed pediatric MFS patients.
  • Significant LV dilation (LVESV z-score > 2) was observed in 42.9% of patients.
  • Multivariable analysis confirmed MAD as an independent predictor of elevated LVESV z-score (RR 3.88, p=0.046), even after accounting for MVP.

Conclusions:

  • Mitral annular disjunction is associated with significant left ventricular dilation in pediatric Marfan syndrome patients.
  • This association appears independent of volume overload from mitral or aortic regurgitation.
  • Further prospective research is warranted to understand the long-term implications of MAD on LV remodeling in pediatric MFS.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
4
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
2
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
3
Mitral Regurgitation II: Clinical features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
5
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
4